US Stock MarketDetailed Quotes

BOLT Bolt Biotherapeutics

Watchlist
  • 0.609
  • -0.009-1.52%
Close Sep 13 16:00 ET
  • 0.610
  • +0.001+0.21%
Post 20:01 ET
23.29MMarket Cap-349P/E (TTM)

Bolt Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.82%-16.14M
28.41%-16.75M
9.12%-69.53M
20.54%-14.27M
-24.52%-16.75M
27.30%-15.11M
3.76%-23.4M
-34.06%-76.5M
-0.89%-17.95M
28.17%-13.45M
Net income from continuing operations
-17.38%-21.2M
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
10.64%-88.1M
26.37%-20M
6.99%-21.76M
Depreciation and amortization
-0.22%457K
-1.93%458K
11.28%1.85M
1.08%467K
5.24%462K
12.25%458K
30.81%467K
39.65%1.67M
27.98%462K
44.41%439K
Other non cash items
7.80%788K
7.51%773K
-8.47%2.95M
7.52%758K
9.09%744K
9.60%731K
-38.60%719K
-62.34%3.23M
29.60%705K
-10.38%682K
Change In working capital
242.47%1.77M
8.55%-8.44M
-222.67%-9.86M
298.84%1.54M
-152.97%-2.69M
128.52%518K
-66.32%-9.23M
-114.91%-3.06M
-114.37%-774K
815.68%5.08M
-Change in prepaid assets
396.21%2.23M
90.56%-130K
49.72%-454K
1,017.89%1.74M
-203.42%-1.27M
150.84%449K
35.05%-1.38M
-58.98%-903K
-102.87%-190K
118.73%1.23M
-Change in payables and accrued expense
-22.65%915K
46.39%-3.54M
-223.30%-3.41M
313.94%1.19M
-85.15%827K
270.22%1.18M
-176.38%-6.61M
-58.54%2.77M
152.28%287K
78.75%5.57M
-Change in other current liabilities
-16.55%-676K
-24.55%-695K
13.37%-2.39M
19.04%-638K
-21.78%-615K
-20.58%-580K
43.41%-558K
-134.89%-2.76M
-127.75%-788K
8.68%-505K
-Change in other working capital
-29.78%-693K
-496.05%-4.07M
-66.79%-3.61M
-809.64%-755K
-35.15%-1.63M
34.80%-534K
-1,239.22%-683K
-113.88%-2.16M
75.37%-83K
-126.58%-1.21M
Cash from discontinued investing activities
Operating cash flow
-6.82%-16.14M
28.41%-16.75M
9.12%-69.53M
20.54%-14.27M
-24.52%-16.75M
27.30%-15.11M
3.76%-23.4M
-34.06%-76.5M
-0.89%-17.95M
28.17%-13.45M
Investing cash flow
Cash flow from continuing investing activities
32.57%18M
-64.81%10.2M
22.77%71.04M
-3.81%15.81M
772.97%12.66M
1,664.52%13.58M
-29.02%28.99M
124.92%57.86M
-21.86%16.44M
109.00%1.45M
Net PPE purchase and sale
--0
--0
89.45%-206K
96.74%-6K
77.55%-165K
92.54%-32K
99.50%-3K
16.47%-1.95M
67.26%-184K
27.59%-735K
Net investment purchase and sale
32.26%18M
-64.81%10.2M
19.11%71.24M
-4.84%15.82M
486.86%12.82M
3,200.68%13.61M
-30.05%28.99M
126.02%59.82M
-23.04%16.62M
114.47%2.19M
Cash from discontinued investing activities
Investing cash flow
32.57%18M
-64.81%10.2M
22.77%71.04M
-3.81%15.81M
772.97%12.66M
1,664.52%13.58M
-29.02%28.99M
124.92%57.86M
-21.86%16.44M
109.00%1.45M
Financing cash flow
Cash flow from continuing financing activities
-49.70%253K
-26.39%106K
0
-99.84%503K
-70.91%144K
0
Net common stock issuance
----
----
-49.70%253K
-26.39%106K
--0
----
----
-99.81%503K
-70.91%144K
--0
Cash from discontinued financing activities
Financing cash flow
----
----
-49.70%253K
-26.39%106K
--0
----
----
-99.84%503K
-70.91%144K
--0
Net cash flow
Beginning cash position
-63.25%6.03M
16.34%12.58M
-62.66%10.81M
-10.32%10.93M
-37.91%15.02M
-64.02%16.4M
-62.66%10.81M
307.32%28.95M
-51.69%12.18M
-59.61%24.18M
Current changes in cash
240.07%1.94M
-217.10%-6.55M
109.74%1.77M
220.17%1.65M
65.91%-4.09M
93.53%-1.39M
-66.39%5.59M
-183.05%-18.14M
-136.77%-1.37M
65.37%-12M
End cash Position
-46.94%7.97M
-63.25%6.03M
16.34%12.58M
16.34%12.58M
-10.32%10.93M
-37.91%15.02M
-64.02%16.4M
-62.66%10.81M
-62.66%10.81M
-51.69%12.18M
Free cash flow
-6.59%-16.14M
28.42%-16.75M
11.12%-69.73M
21.31%-14.27M
-19.23%-16.91M
28.62%-15.14M
6.09%-23.4M
-32.07%-78.46M
1.20%-18.14M
28.14%-14.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.82%-16.14M28.41%-16.75M9.12%-69.53M20.54%-14.27M-24.52%-16.75M27.30%-15.11M3.76%-23.4M-34.06%-76.5M-0.89%-17.95M28.17%-13.45M
Net income from continuing operations -17.38%-21.2M36.33%-10.81M21.45%-69.2M10.47%-17.9M25.29%-16.26M20.33%-18.06M28.29%-16.98M10.64%-88.1M26.37%-20M6.99%-21.76M
Depreciation and amortization -0.22%457K-1.93%458K11.28%1.85M1.08%467K5.24%462K12.25%458K30.81%467K39.65%1.67M27.98%462K44.41%439K
Other non cash items 7.80%788K7.51%773K-8.47%2.95M7.52%758K9.09%744K9.60%731K-38.60%719K-62.34%3.23M29.60%705K-10.38%682K
Change In working capital 242.47%1.77M8.55%-8.44M-222.67%-9.86M298.84%1.54M-152.97%-2.69M128.52%518K-66.32%-9.23M-114.91%-3.06M-114.37%-774K815.68%5.08M
-Change in prepaid assets 396.21%2.23M90.56%-130K49.72%-454K1,017.89%1.74M-203.42%-1.27M150.84%449K35.05%-1.38M-58.98%-903K-102.87%-190K118.73%1.23M
-Change in payables and accrued expense -22.65%915K46.39%-3.54M-223.30%-3.41M313.94%1.19M-85.15%827K270.22%1.18M-176.38%-6.61M-58.54%2.77M152.28%287K78.75%5.57M
-Change in other current liabilities -16.55%-676K-24.55%-695K13.37%-2.39M19.04%-638K-21.78%-615K-20.58%-580K43.41%-558K-134.89%-2.76M-127.75%-788K8.68%-505K
-Change in other working capital -29.78%-693K-496.05%-4.07M-66.79%-3.61M-809.64%-755K-35.15%-1.63M34.80%-534K-1,239.22%-683K-113.88%-2.16M75.37%-83K-126.58%-1.21M
Cash from discontinued investing activities
Operating cash flow -6.82%-16.14M28.41%-16.75M9.12%-69.53M20.54%-14.27M-24.52%-16.75M27.30%-15.11M3.76%-23.4M-34.06%-76.5M-0.89%-17.95M28.17%-13.45M
Investing cash flow
Cash flow from continuing investing activities 32.57%18M-64.81%10.2M22.77%71.04M-3.81%15.81M772.97%12.66M1,664.52%13.58M-29.02%28.99M124.92%57.86M-21.86%16.44M109.00%1.45M
Net PPE purchase and sale --0--089.45%-206K96.74%-6K77.55%-165K92.54%-32K99.50%-3K16.47%-1.95M67.26%-184K27.59%-735K
Net investment purchase and sale 32.26%18M-64.81%10.2M19.11%71.24M-4.84%15.82M486.86%12.82M3,200.68%13.61M-30.05%28.99M126.02%59.82M-23.04%16.62M114.47%2.19M
Cash from discontinued investing activities
Investing cash flow 32.57%18M-64.81%10.2M22.77%71.04M-3.81%15.81M772.97%12.66M1,664.52%13.58M-29.02%28.99M124.92%57.86M-21.86%16.44M109.00%1.45M
Financing cash flow
Cash flow from continuing financing activities -49.70%253K-26.39%106K0-99.84%503K-70.91%144K0
Net common stock issuance ---------49.70%253K-26.39%106K--0---------99.81%503K-70.91%144K--0
Cash from discontinued financing activities
Financing cash flow ---------49.70%253K-26.39%106K--0---------99.84%503K-70.91%144K--0
Net cash flow
Beginning cash position -63.25%6.03M16.34%12.58M-62.66%10.81M-10.32%10.93M-37.91%15.02M-64.02%16.4M-62.66%10.81M307.32%28.95M-51.69%12.18M-59.61%24.18M
Current changes in cash 240.07%1.94M-217.10%-6.55M109.74%1.77M220.17%1.65M65.91%-4.09M93.53%-1.39M-66.39%5.59M-183.05%-18.14M-136.77%-1.37M65.37%-12M
End cash Position -46.94%7.97M-63.25%6.03M16.34%12.58M16.34%12.58M-10.32%10.93M-37.91%15.02M-64.02%16.4M-62.66%10.81M-62.66%10.81M-51.69%12.18M
Free cash flow -6.59%-16.14M28.42%-16.75M11.12%-69.73M21.31%-14.27M-19.23%-16.91M28.62%-15.14M6.09%-23.4M-32.07%-78.46M1.20%-18.14M28.14%-14.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data